Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 12 hours ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Cancer breakthrough as scientists develop jab that could provide miracle cure
Daily Express· 2 hours agoA revolutionary skin cancer vaccine being tested on British patients offers hope of a cure for the...
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Bloomberg Law· 9 hours agohave reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology. The complaint relates to patents discovered by researchers who ...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 8 hours agoWhat's Going On With Pfizer Stock On Thursday?
BioNTech SE to Post Q1 2024 Earnings of $1.26 Per Share, HC Wainwright Forecasts (NASDAQ:BNTX)
ETF DAILY NEWS· 4 days agoBioNTech SE (NASDAQ:BNTX – Free Report) – Stock analysts at HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for shares of BioNTech ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 8 hours agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
Morningstar· 4 days agoBioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally ...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 3 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Brokerages Set BioNTech SE (NASDAQ:BNTX) PT at $120.40
ETF DAILY NEWS· 7 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ten ratings firms that are currently covering the stock, Marketbeat ...